Viewing StudyNCT06258642



Ignite Creation Date: 2024-05-06 @ 8:06 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06258642
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-14
First Post: 2024-02-06

Brief Title: Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
Sponsor: Fudan University
Organization: Fudan University

Conditions & Keywords Data

Conditions:
Name
Small Cell Lung Cancer Recurrent
Keywords:
Name View
Small Cell Lung Cancer View
liposomal irinotecan View